Defiance Autism Impact ETF (ASD)
NASDAQ: ASD · Real-Time Price · USD
26.92
+0.18 (0.66%)
At close: Aug 4, 2026, 4:00 PM EDT
26.92
0.00 (0.00%)
After-hours: Aug 4, 2026, 4:15 PM EDT
ASD Holdings Information
ASD is an equity ETF with a total of 41 individual holdings. The top holdings are Definium Therapeutics stock at 4.51%, Neuren Pharmaceuticals at 3.22%, Otsuka Holdings at 3.15%, LifeStance Health Group at 3.05%, and ACADIA Pharmaceuticals at 3.04%.
Total Holdings
41
Top 10 Percentage
31.10%
Asset Class
Equity
ETF Category
Health
Assets
1.34M
PE Ratio
15.00
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics, Inc. | 4.51% |
| 2 | ASX: NEU | Neuren Pharmaceuticals Limited | 3.22% |
| 3 | TYO: 4578 | Otsuka Holdings Co., Ltd. | 3.15% |
| 4 | LFST | LifeStance Health Group, Inc. | 3.05% |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 3.04% |
| 6 | BFAM | Bright Horizons Family Solutions Inc. | 2.92% |
| 7 | BTSG | BrightSpring Health Services, Inc. | 2.83% |
| 8 | LON: PSON | Pearson plc | 2.80% |
| 9 | BMY | Bristol-Myers Squibb Company | 2.79% |
| 10 | ABBV | AbbVie Inc. | 2.78% |
| 11 | ACHC | Acadia Healthcare Company, Inc. | 2.77% |
| 12 | RVTY | Revvity, Inc. | 2.74% |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 2.68% |
| 14 | JSE: LHC | Life Healthcare Group Holdings Limited | 2.68% |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 2.66% |
| 16 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 2.66% |
| 17 | SWX: ROP | Roche Holding AG | 2.66% |
| 18 | AVXL | Anavex Life Sciences Corp. | 2.64% |
| 19 | RGEN | Repligen Corporation | 2.64% |
| 20 | STO: MCOV.B | Medicover AB (publ) | 2.63% |
| 21 | JNJ | Johnson & Johnson | 2.61% |
| 22 | TYO: 4507 | Shionogi & Co., Ltd. | 2.54% |
| 23 | GHC | Graham Holdings Company | 2.54% |
| 24 | BWAY | BrainsWay Ltd. | 2.54% |
| 25 | SWX: NOVN | Novartis AG | 2.53% |
As of Jul 30, 2026